RAC audits target infusion and injection billing: defending CPT 96365‑96367 drug administration documentation under 2026 CMS scrutiny

The visit that blew up a week’s worth of claims

Last month one of our hematology clients had ten claims kicked back by the Region 5 RAC. Same issue every time: 96365 billed for the IV infusion start, 96366 for additional hours, but the medical record never explicitly showed the start and stop times for each bag. UnitedHealthcare and Anthem piled on and launched post‑pay reviews. The exposure hit about $8,400 in recoupment risk for what looked like clean claims.

CMS’ audit focus for 2026 isn’t new, just sharper. The RACs are pulling infusion and injection encounters that smell like “template” documentation. If your EMR auto‑stamps times or prep instructions without a manual edit, it’s a flag. And with CPT 96365‑96367 ranging $92 to $136 in allowed reimbursement per hour under the 2026 MPFS (facility rate), they’re digging hard for errors. Real money drives interest, every time.

CMS and RAC teams are aligning on drug admin accuracy

The January 2026 Medicare Program Integrity Transmittal 12482 spelled it out: any service billed under the 96365‑96379 range must include manual evidence of administration start and stop times, substance name, route, and provider supervision level. The OIG’s December 2025 audit highlighted four MAC regions with overpayments averaging 17 percent for infusion codes, mostly from missing documentation or double billing flushes (often 96374 or 96360 used wrong).

RACs aren’t guessing anymore. They’re matching your 837 claims to PBM data. Cigna and Aetna already reject high‑cost drug claims when J‑code volumes don’t tie to infusion duration. For example, J9312 (rituximab) claims logged as 30‑minute infusions rarely pass medical review now. CMS’ stance is blunt: under 31 minutes, 96365 is invalid, bill 96374 instead.

Where most documentation falls apart

Let’s be blunt. The problem isn’t coding, it’s lazy notes. The RAC flags non‑compliant 96365‑96367 sequences fast when it sees these patterns:

• No charted start/stop times per bag or concurrent infusion
• Automatic EMR header showing identical minute for both
• Missing supervising provider signature or IV access detail
• Flush coded separately same day without a qualifying new infusion

Example: the nurse writes, “Infusion ran 12:00 to 2:00 p.m.” Looks fine, until you realize the saline pre‑infusion started 11:50 a.m. That’s 10 minutes of lost billable therapeutic time if not shown. RAC extrapolation multiplies quick, ten charts can spiral into $50k in modeled overpayments against twelve months of volume. Ugly, and fast.

Concurrent infusions and why modifier 59 still matters

Some payers keep tripping on concurrent infusions, think chemo plus hydration at once. Anthem and Humana routinely deny the second line when modifier 59 is missing on 96367 or 96368. The 2026 HCPCS update reaffirmed that concurrent infusions require distinct drug lines and separate start‑stop documentation. Copy‑forward time blocks won’t save you from compliance review.

If you’re billing Aetna for infliximab and iron sucrose simultaneously, line two should read, “Infusion #2: iron sucrose, started 12:10, stopped 1:00, separate IV line, distinct pump.” That single sentence defends two units of 96367 at $74 each, on top of 96365. Skip it, and you’ll eat the denial.

The before/after fix that protects revenue

We ran a recovery fix for that hematology group. Before revision, notes said only:

“Patient tolerated IV infusion well. Total time = 2 hours.”

Afterward, nurses charted:

“Start 12:03 p.m., stop 2:06 p.m. Drug: rituximab 600 mg IV over 2 hours. Line 1. Supervising MD: Dr. Lake. Flush started 2:07 p.m., stopped 2:10 p.m., no charge per policy.”

The difference was everything. CMS reviewers cleared all re‑submissions, and the RAC dropped the recoupment entirely. Those notes also aligned our J9312 quantity validation with infusion time (2 hours × 300 mg/hr). Exactly the format spelled out in the 2026 transmittal. Tight enough to impress any auditor, if that’s even possible.

Don’t forget routine hydration

UHC quietly turned hydration infusions (96360, 96361) into their next data‑match for revenue validation. When hydration runs in the same session as chemo, it must start after chemo ends, or it’s denied as “included.” Document overlap and you’ll see an offset on your remit. UHC’s March 2026 policy and Cigna’s April Smart Edit updates both enforce this logic. We’ve tested it, they’re consistent. So time those fluids carefully.

What to do Monday morning

Look, the RACs aren’t bluffing. CMS set 2026 target recoveries for drug admin codes at $58 million nationwide. You can’t argue intent when start and stop times are gone. The fix is simple but strict:

Audit ten random infusion notes from February. Are start/stop times visible, precise, tied to a specific drug? If not, add a mandatory EMR field. Require drug, dose, route, supervising provider, start, stop, any complications. No field, no claim.

Train nurses to flag any EMR entry logging identical start and stop times. That one step dodges back‑end denials later. Billers should cross‑check J‑code quantity against documented duration, we run a hard rule: infusion ≤ 30 min + code 96365 = fail pre‑bill review. Harsh, but effective.

CMS isn’t trying to erase infusion revenue. They just want proof it happened. Do that consistently and your 96365‑96367 claims stand up, 2026 or not. And that’s good enough for me right now.